Home » Topics » BioWorld Science

BioWorld Science
RSS

INSERM and Bioprojet describe a new histamine H3 receptor antagonist

Sep. 6, 1996

Tiagabine clinical data reported at congress this week

Sep. 6, 1996

Fosphenytoin launch imminent

Sep. 6, 1996

Mechanism-based enzyme inhibitor may serve as a lead for new anticonvulsants

Sep. 6, 1996

Xenova forms new U.S. subsidiary

Sep. 6, 1996

ICN to acquire Hungarian pharmaceutical company

Sep. 6, 1996

MicroCarb name change

Sep. 6, 1996

Zynaxis terminates agreement in principle for sale of chemistry division

Sep. 6, 1996

Baxter to acquire Immuno AG

Sep. 6, 1996

Cellegy issued patent covering novel drug delivery system

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...